Montebello Diagnostics As
Montebello Diagnostics AS is a Norwegian-owned specialty distributor founded in 1997, supplying diagnostic instruments, reagents, and rapid tests from 14+ international manufacturers to hospital microbiology, food safety, primary healthcare, and research laboratories across Norway.
- Company typePrivate
- Founded1997
- HeadquartersOslo, Norway
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Montebello Diagnostics As does
Montebello Diagnostics AS is a Norwegian-owned, privately held distributor of diagnostic products founded in 1997 by Ingrid Brobakk and Alf Gervin, headquartered at Ole Deviks vei 16A in Oslo. The company supplies diagnostic instruments, reagents, and rapid tests to medical, food, and veterinary laboratories across Norway, with a core focus on hospital microbiology laboratories and an expanding presence in food safety, primary healthcare, and research segments. Its 8-person team includes 5 specialists with direct practical experience from microbiology laboratories and decades of combined bioengineering expertise.
The company distributes a broad portfolio of diagnostic platforms from international manufacturers, including the Hologic Panther molecular diagnostics system (using Aptima technology), ELITe BeGenius and InGenius systems, the Eazyplex LAMP rapid molecular system, Dynex DS2 and DSX ELISA automation robots, Vivalytic PCR point-of-care analyzers, R-biopharm reagents and rapid tests, Liofilchem MIC test strips and culture media, Gold Standard Diagnostics food-safety and veterinary products, and the recently launched ALL IN TRIPLEX combined rapid antigen test (the first IVDR CE-certified combined self-test for bronchiolitis, influenza, and COVID-19 in Europe). Distribution is supplemented by TechCyte AI-assisted fecal ova and parasite detection and proprietary-method reagent lines spanning ELISA, real-time PCR, immunochromatography, agglutination, and immunofluorescence.
The business model is B2B specialty distribution with quote-based, non-public pricing. Revenue is generated through sales of instruments, reagents, consumables, and rapid tests, supported by close supplier relationships enabling technical application support, installation, training, and after-sales service. Customer acquisition is driven by direct enterprise sales through product specialists, complemented by active participation in Norwegian and Nordic clinical microbiology conferences (Høstkonferansen, Substratkonferansen, DSKM, Nordic Pathology Meeting, ECCMID) and hosting of supplier user meetings. The company has remained under founder and employee ownership since 1997, with no external venture capital, private equity, or parent-company relationships identified.
Montebello Diagnostics As firmographics
Firmographics- Name
- Montebello Diagnostics As
- Legal name
- Montebello Diagnostics AS
- Website
- https://montebello.no
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Montebello Diagnostics AS is a Norwegian-owned specialty distributor founded in 1997, supplying diagnostic instruments, reagents, and rapid tests from 14+ international manufacturers to hospital microbiology, food safety, primary healthcare, and research laboratories across Norway.
- Ownership category
- akta.pro rank
Montebello Diagnostics As industry classification
Industry- Product category
- Medical Diagnostics Distribution
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)
- akta.pro secondary industries
- Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Food Testing Laboratories (Microbiological, Chemical, Allergen) (AFALAAAA)
Keywords
Where Montebello Diagnostics As is headquartered
LocationHeadquarters
- HQ city
- Oslo
- HQ country
- Norway
- HQ region
- Europe
Offices1 record
Markets served
Montebello Diagnostics As business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Diagnostic products distribution: Distribution of diagnostic products including instruments, reagents, rapid tests, and laboratory supplies to healthcare and food safety laboratories. Revenue generated through product sales with close supplier relationships ensuring rapid delivery and solid user support.
- Specialized laboratory instruments: Sale of laboratory instruments including Hologic Panther system, Dynex ELISA robots, Vivalytic PCR analyzer, and associated automation solutions
- Diagnostic test reagents and consumables: Supply of diagnostic test reagents, culture media, rapid tests, and consumable supplies across microbiology, immunology, cytology and food safety applications
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
Montebello Diagnostics As product offering
Product offeringCore offering
Montebello Diagnostics AS is a Norwegian-owned distributor of diagnostic tests, instruments, and reagents serving medical, food, and veterinary laboratories. Founded in 1997 and headquartered in Oslo, the company supplies products from leading manufacturers such as Hologic, BioFire, R-biopharm, Liofilchem, EUROIMMUN, and Vircell to hospital microbiology labs, food labs, primary healthcare, and research institutions.
Product overview
Montebello Diagnostics As is a Norwegian-owned distributor of medical diagnostic products founded in 1997, serving microbiology laboratories, food analysis laboratories, primary healthcare, and research laboratories. The company offers a comprehensive portfolio of diagnostic products across multiple categories: Microbiology (bacteriology, molecular diagnostics, mycology, sepsis, parasitology, infection immunology), Cytology (HPV testing, ThinPrep systems, AI-assisted cervical screening), Immunology and Biochemistry (therapeutic drug monitoring, serological assays, LC/MS), Point-of-Care Testing (Vivalytic PCR analyzer, rapid tests), Food Analysis (pathogen PCR, mycotoxins, allergens, surface monitoring), Veterinary Diagnostics (PCR, ELISA, culture media, rapid tests), and Gastroenterology (calprotectin, elastase, TDM). Key distributed platforms include Hologic Panther, ELITe BeGenius/InGenius, Eazyplex LAMP, Dynex ELISA automation, RIDA/Biopharm systems, and Gold Standard Diagnostics products.
Differentiator
Problem solved
Functional benefit
Products and services
- Hologic Panther Molecular Diagnostics Systems
- BioFire FilmArray Panels
- R-biopharm Food Diagnostics Kits
- Liofilchem Antimicrobial Susceptibility Testing Products
- EUROIMMUN Autoimmune Diagnostics
- Vircell Infectious Disease Diagnostics
- Mast Group Urine Screening and ELISA Kits
- rqmicro Single-Cell Microbiology Solutions
- Quanta BioDesign Bioconjugates
- Alphatec Scientific Laboratory Products
Quantifiable outcome
- ALL IN TRIPLEX rapid test achieves 99% correlation with nasopharyngeal PCR testing for COVID-19
- +2 more outcomes
Companies that use Montebello Diagnostics As
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Montebello Diagnostics As technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Montebello Diagnostics As partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core.
- HologiccoreExclusive Norwegian distributor for Hologic's fully automated Panther molecular analysis platform using patented Aptima technology. Also distributes ThinPrep liquid-based cytology products and Panther Fusion real-time PCR system. Products include assays for CT/NG, M.genitalium, T.vaginalis, quantitative HIV, HCV, HBV testing.
- R-biopharmcoreDistributes R-biopharm reagents and automation for serology (RIDASCREEN), rapid tests (RIDAQUICK), and real-time PCR (RIDAGENE). RIDAGENE products offer multiplexing for respiratory agents, fecal agents, hospital-acquired infections, STIs, and skin infections.
- LiofilchemcoreNorwegian distributor for Liofilchem MIC Test Strips for Minimum Inhibitory Concentration determination, culture media, chromogenic plates, and rapid detection products. Also distributes Coris BioConcept rapid antigen detection tests and RESIST-range products for carbapenemase detection.
- AmplexDiagnostics GmbH (eazyplex)coreDistributes eazyplex molecular rapid diagnostics system - a patented system that is compact, fast, can analyze up to 8 samples per run in 15-25 minutes without DNA extraction. Tests mainly for antibiotic resistance detection including SuperBug CRE kits.
- ELITechGroupcoreDistributes ELITe BeGenius and InGenius molecular diagnostic systems and associated ELITe MGB kits. Products cover blood-borne viruses, respiratory infections, STIs, gastrointestinal infections, transplant monitoring, oncohematology, meningitis, and healthcare-associated infections.
- Gold Standard DiagnosticscoreDistributes comprehensive portfolio including SENSIStrip mycotoxin rapid tests, BACGene real-time PCR kits, lateral flow tests for veterinary diagnostics, INgezim ELISA kits, and Hurricane Dx autoimmune CLIA systems. Major supplier for food safety and veterinary diagnostics.
- Bosch Healthcare (Vivalytic)coreDistributes Vivalytic PCR analyzer for point-of-care testing offering rapid cartridge-based tests for Bordetella, SARS-CoV-2/Flu/RSV, bacterial meningitis, MRSA/SA, STIs, UTI, and norovirus among others.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Montebello Diagnostics As competitors and assessment
Company assessmentBroad incumbents
- AddLife AB: Swedish publicly listed life-science solutions group owning multiple niche distributors across the Nordics; larger-scale peer with similar exclusive-distribution and lab-procurement thesis but broader portfolio and M&A capacity.
- Cepheid (Danaher): Manufacturer of GeneXpert molecular diagnostic systems competing directly with the Hologic Panther and Eazyplex platforms Montebello distributes; an upstream supplier-disrupter that could pressure distributor economics in molecular Dx.
- bioMérieux SA: Global leader in microbiology diagnostics manufacturing - many of the test categories Montebello distributes (culture media, chromogenic plates, AST, immunoassays) overlap with bioMérieux's own products, making it both a supplier-adjacent partner and a competitive threat to distributor margins.
- Henry Schein Inc. Global medical and dental supplies distributor with broad Nordic presence; competes for the same hospital and primary-care procurement budgets but lacks Montebello's microbiology specialization.
- Bio-Rad Laboratories Inc. Major manufacturer of clinical diagnostics and life science research products with direct sales in Europe; competes with Montebello's distributed ELISA, molecular and quality-control reagent offerings and could choose to bypass independent distributors.
Direct peers
- AH Diagnostics A/S: Denmark-based Nordic distributor of diagnostic products and laboratory equipment, with overlapping microbiology and molecular diagnostics portfolio and similar small-team, exclusive-distributor business model.
- BioNordika AB: Swedish-headquartered Nordic distributor of life science and diagnostic products with similar exclusive distribution agreements and lab-customer base; closest head-to-head comparator in regional footprint and supplier model.
- Abacus dx Pty Ltd: Specialist diagnostics distributor operating in Australia and Nordic-adjacent markets with comparable exclusive-distributor arrangements and microbiology/IVD focus, competing for similar manufacturer partnerships.
Others
- Hologic Inc. Montebello's largest exclusive supplier for the Panther molecular platform, but also a structural risk: Hologic periodically reshapes its European distributor network and could bypass Montebello with direct sales in Norway.
- Eurofins Scientific SE: Global laboratory testing services giant with significant food-safety and clinical-diagnostics lab operations in Norway; adjacent rather than direct competitor - represents the lab-services side of the value chain that Montebello's diagnostic products ultimately feed.
Market position
Strengths4 records
Weaknesses3 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Montebello Diagnostics As social profiles
Digital presenceMontebello Diagnostics As compliance and trust
Trust signalCompliance2 records
Montebello Diagnostics As financial estimates
Financial estimateRevenue estimate
Valuation estimate
Montebello Diagnostics As leadership team
Management profileNumber of profiles
Profiles10 records
Montebello Diagnostics As funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Montebello Diagnostics As M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Montebello Diagnostics As
What does Montebello Diagnostics As do?
Montebello Diagnostics AS is a Norwegian-owned distributor of diagnostic tests, instruments, and reagents serving medical, food, and veterinary laboratories. Founded in 1997 and headquartered in Oslo, the company supplies products from leading manufacturers such as Hologic, BioFire, R-biopharm, Liofilchem, EUROIMMUN, and Vircell to hospital microbiology labs, food labs, primary healthcare, and research institutions.
Is Montebello Diagnostics As a public or private company?
Montebello Diagnostics As is a private company. It is classified as management employee owned and is currently operating.
When was Montebello Diagnostics As founded?
Montebello Diagnostics As was founded in 1997. It employs 1 to 10 people.
Where is Montebello Diagnostics As based?
Montebello Diagnostics As is headquartered in Oslo, Norway, in the Europe region.
How does Montebello Diagnostics As make money?
Three revenue lines are on record. Diagnostic products distribution is the primary driver. The others are specialized laboratory instruments and diagnostic test reagents and consumables.
Who are Montebello Diagnostics As's main competitors?
Broad incumbents on record are AddLife AB, Cepheid (Danaher), bioMérieux SA, Henry Schein Inc. and Bio-Rad Laboratories Inc.. Direct peers are AH Diagnostics A/S, BioNordika AB and Abacus dx Pty Ltd. Others are Hologic Inc. and Eurofins Scientific SE.
Does Montebello Diagnostics As have an API?
No public API is recorded for Montebello Diagnostics As.
What industry is Montebello Diagnostics As in?
Montebello Diagnostics As's product category is Medical Diagnostics Distribution. Its primary akta.pro industry code is HLAHAAAC, Microbiology & Infectious Disease Diagnostics (Culture/ID/AST), with a secondary code of HLAGADAE, Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility). Its NAICS code is 3391 and its SIC code is 2835.